LCM
RPRX icon

Landscape Capital Management’s Royalty Pharma RPRX Stock Holding History

Landscape Capital Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-28,587
Closed -$1.01M – 872
2025
Q3 		$1.01M Buy
28,587
+19,296
+208% +$699K 0.06% 368
2025
Q2 		$335K Buy
+9,291
New +$308K 0.03% 520
2020
Q3 		– Sell
-122,349
Closed -$5.94M – 355
2020
Q2 		$5.94M Buy
+122,349
New +$6.06M 0.98% 32

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Landscape Capital Management's RPRX Position: Q4 2025 in Review

Landscape Capital Management sold out of Royalty Pharma (RPRX) in Q4 2025, closing a stake of 28,587 shares — an estimated $1.01M sold.

Landscape Capital Management first reported a position in RPRX in Q2 2020 and held it in 3 quarters. The position peaked at $5.94M in Q2 2020. 538 funds tracked by Wall St. Rank hold RPRX as of Q4 2025.

  • Landscape Capital Management reported no remaining Royalty Pharma position as of Q4 2025 after selling out during the quarter.
  • Landscape Capital Management sold 28,587 Royalty Pharma shares in Q4 2025, an estimated $1.01M.
  • Landscape Capital Management first reported a position in Royalty Pharma in Q2 2020 and held it in 3 quarters.
  • Landscape Capital Management's Royalty Pharma position peaked at $5.94M in Q2 2020.
  • 538 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2025.

Based on Landscape Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.